Axon initial segments (AISs) and nodes of Ranvier (NRs) are essential regions for saltatory conduction of the action potential along the axon. These two domains are enriched in similar multimolecular complexes, which include voltage-gated sodium channels (Na v ), NF186 (neurofascin 186), NrCAM (neuron glia-related cell adhesion molecule), and cytoskeleton linkers ankyrin G (AnkG) and ␤IV-spectrin. 
Introduction
Saltatory electric conduction in myelinated axons depends on the compartmentalization of voltage-gated sodium channels (Na v ) in two specialized axonal domains of the neuron: the axon initial segment (AIS) and the node of Ranvier (NR). Na v channels are part of multimolecular complexes, which are very similar in AISs and NRs, including transmembrane adhesion molecules of the Ig superfamily [neuron glia-related cell adhesion molecule (Nr-CAM) and neurofascin 186 (NF186)] and the cytoskeletalassociated proteins ankyrin G (AnkG) and ␤IV-spectrin (Salzer, 2003) . Physiological processes that specify NR and AIS formation and their initiation have been extensively investigated and are now beginning to be well understood.
Initiation of assembly of NR components strongly depends on NF186. In the peripheral nervous system (PNS), NF186 is recruited to the node by a Schwann cell protein, gliomedin (Eshed et al., 2005) , and acts as a docking site for AnkG (Dzhashiashvili et al., 2007) . The subsequent formation of NRs is critically dependent on AnkG (Dzhashiashvili et al., 2007) , which serves as a protein scaffold to which both ␤IV-spectrin and Na v bind (Lemaillet et al., 2003; Yang et al., 2007) . AnkG also acts as a critical organizer of AISs (Zhou et al., 1998; Jenkins and Bennett, 2001; Pan et al., 2006; Hedstrom et al., 2007; Yang et al., 2007) . However, unlike NRs, AISs are intrinsically specified, forming independently of glial signals (Catterall, 1981; Alessandri-Haber et al., 1999) .
Less is known about the long-term stabilization of NRs and AISs, although ␤IV-spectrin, which is targeted to AISs after AnkG and NF186 (Jenkins and Bennett, 2001) , has been proposed to play such a role Yang et al., 2004 Yang et al., , 2007 . In "quivering" qv 3J mice, which are devoid of ␤IV-spectrin in the CNS, NRs are still able to form but are severely disorganized (Yang et al., 2004) . Furthermore, AISs form normally in qv 3J mice but are destabilized with increasing age (Yang et al., 2007 ). The precise mechanisms governing the stabilization of the multimolecular complexes are not yet known, and a full understanding of these processes will require the identification and characterization of the proteins involved.
SCHIP-1 was identified in a yeast two-hybrid screen as a partner of the tumor suppressor protein schwannomin/merlin and is highly enriched in the brain (Goutebroze et al., 2000) . Two isoforms resulting from alternative splicing were originally described, and more recently, another isoform containing an IQ motif (Bähler and Rhoads, 2002) , IQCJ-SCHIP-1, has been reported as the product of a candidate gene for language disorder (Kwasnicka-Crawford et al., 2006) . In this study, we identify IQCJ-SCHIP-1 as a novel component of AIS and NR multimolecular complexes and investigate its involvement in AIS and NR formation and maintenance. Our results suggest that IQCJ-SCHIP-1 is likely to play a role in mature AISs and NRs. We propose that IQCJ-SCHIP-1 might participate in long-term stabilization or function of AISs and NRs.
Materials and Methods

Mutant mice
Cerebellum-specific AnkG knock-out (cs-AnkG-KO) mice (Zhou et al., 1998) and C57BL/6JSpn4 qv3J/ϩ mutant mice (Parkinson et al., 2001 ) were generous gifts from Prof. V. Bennett (Duke University Medical Center, Durham, NC) and J. Devaux (Centre National de la Recherche Scientifique, UMR6231 Marseilles, France), respectively. Two-monthold homozygous mice were analyzed.
Immunocytochemistry
Immunostaining of cryostat sections (10 m) of rat and mouse tissues was performed as described previously (Goutebroze et al., 2003) using methanol/acetone fixation in all cases. Images were acquired using a Leica SP2 confocal laser-scanning microscope (Leica).
Antibodies
Rabbit antibody ␣17141 and chicken antibody ␣964 were described previously (Goutebroze et al., 2000) . Antibodies ␣16199 and ␣15013 were obtained by immunizing rabbits with glutathione S-transferase (GST) fused to the first 22 aa of SCHIP-1a and SCHIP-1b (GST-a/b), and the first 97 aa of IQCJ-SCHIP-1 (GST-IQCJ), respectively. Commercial antibodies were from the following sources: Na v ␣-subunit, pan-specific mouse monoclonal antibody (mAb; clone K58/35), Sigma-Aldrich; Caspr/paranodin, mouse mAb (clone K65/35), Antibodies Incorporated; AnkG, mouse mAb (clone 463), EMD Biosciences; calmodulin, mouse mAb, Millipore; MAP2 chicken polyclonal antibody, Abcam; green fluorescent protein (GFP), mouse mAb, Roche; GST, rabbit polyclonal antibody (gift from F. Castets, Inserm U641, Marseilles, France); secondary antibodies for immunocytochemistry (Alexa 488/546/633-conjugated), Invitrogen; IRDye800CW-conjugated donkey anti-rabbit and antimouse antibodies, Rockland Immunochemicals.
Cell culture, immunoblotting, and immunofluorescence
COS-7 cell transfection and immunoblotting were performed as described previously (Goutebroze et al., 2003) . Primary hippocampal neurons were prepared from embryonic day 18 rats according to Goslin and Banker (1989) , with slight modifications (Garrido et al., 2003) . Cells were fixed in methanol during 10 min at Ϫ20°C before incubation for 45 min in blocking buffer (0.22% gelatin, 0.066% saponin, and 1% normal goat serum in phosphate buffer). Primary antibodies and secondary antibodies diluted in blocking buffer were applied for 60 and 45 min, respectively. Coverslips were mounted in FluorSave reagent (EMD Biosciences).
GST pull-down assays
Interaction with calmodulin. Bovine calmodulin (5 g; EMD Biosciences) was incubated with 5 g of GST-fusion proteins in 20 mM Tris HCl, pH 8, 100 mM KCl, 0.1 mM EDTA, 10% glycerol, 5 mM MgCl 2 , 0.5 mM DTT, and 0.5% NP-40 containing either 2 mM CaCl 2 or 2 mM EGTA.
Interaction with ankyrin. HEK293A cells transfected with GFP-SCHIP-1 plasmids were lysed in 50 mM Tris-HCl, pH 7.6, 0.9% NaCl, and 1 mM EDTA, and solubilized with 1% Triton X-100. Lysates were incubated in this buffer with 5 g of GST-Ank-membrane-binding domain [MBD; which contains the region of ANK repeats (residues 1-862) of human Ankyrin B] .
For all pull-down experiments, mixtures were incubated at 4°C for 3 h with glutathione-agarose beads. Beads were washed with the respective buffer, and bound proteins were eluted in sample buffer at 100°C and separated by SDS-PAGE. Calmodulin and GFP-tagged proteins were detected by immunoblotting, and GST proteins visualized by Coomassie blue staining or anti-GST immunoblotting.
Mouse SCHIP-1 isoform identification and cloning
The sequences coding for the mouse homologues of the previously described human SCHIP-1 isoforms (Goutebroze et al., 2000; KwasnickaCrawford et al., 2006) were identified by screening the mouse genome and EST databases at NCBI using the basic local alignment search tool. The corresponding cDNAs were isolated by reverse transcription (RT)-PCR experiments from mouse brain mRNA and sequenced. The cDNA sequences were deposited in GenBank (accession numbers: SCHIP-1a, EU163407; SCHIP-1b, EU163408; IQCJ-SCHIP-1, EU163409). For expression in COS-7 cells, the cDNAs were subcloned into the pcDNA3.1 vector (Invitrogen). For expression in E. coli, the appropriate cDNA fragments were subcloned in the pGEX-2T vector (GE Healthcare).
Results
SCHIP-1 is a novel axonal component of AISs and NRs
We previously demonstrated that SCHIP-1 is highly expressed in brain (Goutebroze et al., 2000) . To determine its localization more precisely, we double immunolabeled mouse brain sections with ␣17141, a previously described antibody to SCHIP-1 (Fig.  1 A) (Goutebroze et al., 2000) and a pan-specific antibody to the ␣-subunits of the sodium channel (panNa v ). SCHIP-1 was highly enriched at the AISs in every observed population of neurons, including hippocampal neurons ( Fig. 1 B) , Purkinje cells (supplemental Fig. 1 A, available at www.jneurosci.org as supplemental material), and cortical neurons (supplemental Fig. 1 B, available at www.jneurosci.org as supplemental material), perfectly overlapping with Na v staining. SCHIP-1 staining seemed to be evenly distributed throughout the entire AISs and was not detectable in the myelinated regions of the axon, the soma, or the dendrites. Throughout the entire brain, all Na v -positive AISs were SCHIP-1 positive and vice versa.
We then examined the distribution of SCHIP-1 in PNS and CNS myelinated fibers. In longitudinal sections of sciatic nerves, SCHIP-1 immunoreactivity was detected at and restricted to NRs, overlapping with Na v staining (Fig. 1C, top) . Sections perpendicular to the nerve axis further revealed that at NRs, SCHIP-1 localization was restricted to the periphery of the axon and was superimposed with Na v (Fig. 1C, bottom) . On longitudinal sections of optic nerves, SCHIP-1 immunoreactivity was restricted to NRs, its position being easily identified by double labeling with antibodies to paranodin/Caspr, an axonal marker of the paranodal regions that flanks NRs (Menegoz et al., 1997) (Fig.  1 D) . Coimmunostaining revealed a complete colocalization with Na v (Fig. 1 E) on longitudinal and perpendicular sections ( Fig.  1 E, left and right insets, respectively). In both PNS and CNS, SCHIP-1 was detected in every NR identified by Na v or paranodin/Caspr staining. Conversely, no SCHIP-1-positive NR was negative for Na v . Immunolabeling performed with another antibody directed against SCHIP-1, the previously described chicken polyclonal antibody ␣964 (Goutebroze et al., 2000) , gave similar results (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material), demonstrating that SCHIP-1 is a novel component of AISs and NRs.
The presence of SCHIP-1 at both NRs and AISs in PNS and CNS suggests that it is located in the axon, as are the other proteins enriched at both NRs and AISs, i.e., AnkG, ␤IV-spectrin, Na v , NrCAM, and NF186. Moreover, careful examination of transverse sections of sciatic nerve stained with SCHIP-1 and Na v antibodies revealed that SCHIP-1 staining precisely overlapped with Na v staining, never surrounding it. In contrast, the immunofluorescence of glial proteins, including gliomedin, ERM (ezrin-radixin-moesin), or syndecans, forms a ring surrounding Na v immunoreactivity (Melendez-Vasquez et al., 2001; Goutebroze et al., 2003; Eshed et al., 2005) .
IQCJ-SCHIP-1, an isoform of SCHIP-1 that binds calmodulin, is enriched at AISs and NRs
Three different isoforms of SCHIP-1 have been described in human (Goutebroze et al., 2000; Kwasnicka-Crawford et al., 2006) . Using a combination of database mining and RT-PCR experiments, we demonstrated that these three isoforms were also expressed in mouse brain (Fig. 1 A) . We used COS-7 cells overexpressing each of these isoforms to characterize our antibodies. Antibody ␣17141 used above for immunolabeling detected SCHIP-1a and IQCJ-SCHIP-1 by immunoblotting ( Fig. 1 F) . To determine which of these two isoforms were enriched at AISs and/or NRs, we raised rabbit antibodies against the distinct N-terminal regions of IQCJ-SCHIP-1 (␣15013) and of SCHIP-1a (␣16199) (Fig. 1 A) . Both ␣15013 and ␣16199 were selective for their cognate antigens, as determined by immunoblotting ( Fig.  1 F) and immunofluorescence (data not shown) in transfected COS-7 cells. Double labeling with ␣15013 and panNa v antibodies revealed that IQCJ-SCHIP-1 was highly enriched at AISs and NRs in PNS (Fig. 1G ) and CNS (data not shown) of adult mice. In contrast, staining was not detectable at AISs or NRs with ␣16199 throughout development, nor in the adult (data not shown), indicating that SCHIP-1a and SCHIP-1b are not localized at AISs and NRs, or are expressed below the antibody detection threshold. Thus, IQCJ-SCHIP-1 appears to be the major, if not the only, isoform of SCHIP-1 at NRs and AISs. IQCJ-SCHIP-1 N-terminal region encompasses a consensus IQ motif, which has been shown to mediate the association of many proteins with calmodulin (Bähler and Rhoads, 2002) (Fig.  1 A) . We investigated the ability of the IQ motif of IQCJ-SCHIP-1 to associate with calmodulin by performing GST pull-down experiments. A GST fusion protein expressing the N-terminal region of IQCJ-SCHIP-1 (GST-IQCJ) precipitated calmodulin only in the absence of Ca 2ϩ (Fig. 1 H) . In contrast, calmodulin was not precipitated when the IQ residues were mutated to alanine (GST-IQCJ-AA) or when the experiments were performed with a GST fusion protein expressing the N-terminal region of SCHIP-1a and SCHIP-1b, which does not contain an IQ motif (GST-a/b). These observations show that IQCJ-SCHIP-1 can interact with calmodulin in the absence of Ca 2ϩ . 
IQCJ-SCHIP-1 accumulation at NRs and AISs occurs after their formation
To evaluate the possible role of IQCJ-SCHIP-1 in the formation of NRs, we compared the timing of IQCJ-SCHIP-1 accumulation with that of other molecular markers. We examined the distribution of IQCJ-SCHIP-1 and Na v during the development of sciatic nerves in rat pups from postnatal days 0 to 6 (P0 to P6). At P6, Na v and IQCJ-SCHIP-1 immunoreactivities were always associated (data not shown). In contrast, at P0, IQCJ-SCHIP-1 immunoreactivity was only identifiable in very few NRs detectable by Na v clusters (Fig.  2 A, arrowhead) , and was not detected in the large majority of them (Fig. 2 A, arrows) . IQCJ-SCHIP-1 staining was also absent from almost every NR in formation (heminodes) (Fig. 2 A, insets) . In addition, no IQCJ-SCHIP-1-positive NR was negative for Na v . A similar developmental pattern of IQCJ-SCHIP-1 expression was observed in NRs of optic nerves (data not shown). Similar results were obtained with antibodies ␣17141, ␣964, and ␣15013. Thus, IQCJ-SCHIP-1 seems to accumulate in NRs after Na v .
To characterize the accumulation of IQCJ-SCHIP-1 at AISs, we used cultured hippocampal neurons, which have the intrinsic ability to form AISs (Winckler et al., 1999) detectable by simultaneous accumulation of AnkG and Na v (Garrido et al., 2003) . In mature hippocampal neurons in culture [day in vitro 23 (DIV 23)], IQCJ-SCHIP-1 immunostaining was highly concentrated at AISs identified by AnkG staining, whereas no signal was observed throughout the dendrites, visualized by MAP2 staining, and in the distal part of the axon (Fig. 2 B) . We compared the time course of IQCJ-SCHIP-1 and AnkG accumulation by quantifying the percentage of hippocampal neurons displaying a positive signal for AnkG or IQCJ-SCHIP-1 at AISs at various stages of maturation between DIV 2 and DIV 24 (Fig. 2C) . The percentage of AnkG-positive cells dramatically increased with time, as reported previously (Yang et al., 2007) . The number of IQCJ-SCHIP-1-positive AISs also increased with maturation time, but the time course of this increase was delayed compared with AnkG. The proportion of IQCJ-SCHIP-1-positive neurons was clearly lower than the number of AnkG-positive neurons at early stages of maturation (Fig. 2C) . Importantly, all IQCJ-SCHIP-1-positive AISs were positive for AnkG. These results show that the accumulation of AnkG at the AISs precedes IQCJ-SCHIP-1 concentration in cultured hippocampal neurons.
IQCJ-SCHIP-1 localization at AISs is lost in the absence of AnkG
Together, our results demonstrating the enrichment of IQCJ-SCHIP-1 in both AISs and NRs raised the possibility that IQCJ-SCHIP-1 could be associated with the multimolecular complexes localized in these axonal domains. To investigate this hypothesis, we examined the distribution of IQCJ-SCHIP-1 at AISs of Purkinje cells of mice in which AnkG is not expressed in the cerebellum (cs-AnkG-KO mice) (Zhou et al., 1998) . In these mice, the deficiency of AnkG prevents the enrichment of all the molecular components of AIS complexes in Purkinje cells (Zhou et al., 1998; Jenkins and Bennett, 2001; Komada and Soriano, 2002; Pan et al., 2006) . This was also the case for IQCJ-SCHIP-1: IQCJ-SCHIP-1 immunoreactivity was not detectable at AISs of Purkinje cells in cs-AnkG-KO mice (Fig. 3B) , whereas it was clearly detectable in wild-type mice (Fig. 3A) . In contrast, IQCJ-SCHIP-1 staining was maintained in the mutant mice in other brain regions, such as cerebral cortex, where AnkG was not disrupted (Fig. 3C ). These results demonstrate that the correct localization of IQCJ-SCHIP-1 at AISs is dependent on AnkG expression. To test whether IQCJ-SCHIP-1 can interact directly with AnkG, we performed GST pull-down assays. A GST-fusion protein expressing the conserved membrane binding domain of ankyrins (GSTAnk-MBD) precipitated GFP fused to SCHIP-1 but not to truncated SCHIP-1 lacking its C-terminal region (GFP-SCHIP-1⌬414 and GFP-SCHIP-1⌬307) (Fig. 3 D, E) . These results suggest that an interaction between the MBD domain of AnkG and the C-terminal part of IQCJ-SCHIP-1 participates in the localization of IQCJ-SCHIP-1 at AISs and NRs.
Accumulation of IQCJ-SCHIP-1 at AISs and NRs is altered in
␤IV-spectrin mutant mice (qv 3J ) To further investigate the molecular mechanisms underlying the association of IQCJ-SCHIP-1 with the multimolecular complexes at AISs and NRs, we examined the distribution of IQCJ-SCHIP-1 in quivering qv 3J mice. These mice carry a spontaneous point mutation in the ␤IV-spectrin gene (Parkinson et al., 2001 ) that results in a dramatic decrease of ␤IV-spectrin accumulation at AISs and NRs. In the CNS, this leads to nodal disorganization, including elongation and enlargement (Yang et al., 2004) . By performing double labeling with antibodies to Na v , we found that IQCJ-SCHIP-1 immunostaining was markedly reduced at AISs of qv 3J mice central neurons, including cortical neurons, compared with wild-type mice (Fig. 4 A, B) . Moreover, we observed that IQCJ-SCHIP-1 accumulation was lost or dramatically reduced in all optic nerve NRs of the mutant mice, compared with wild-type mice (Fig. 4C,D; supplemental Fig. 3 A, B , available at www.jneurosci.org as supplemental material). At PNS nodes, where ␤IV-spectrin disruption is less severe than in the CNS (Yang et al., 2004) , IQCJ-SCHIP-1 nodal enrichment was lost at 6 months (supplemental Fig. 4 , available at www.jneurosci.org as supplemental material), although it could be occasionally detected at 2 months (data not shown). Yang et al. (2004 Yang et al. ( , 2007 showed that CNS AISs and NRs of qv 3J mice lack detectable ␤IV- spectrin, whereas clustering of other components, including Na v and AnkG, is relatively maintained. Therefore, our observations indicate that the accumulation of IQCJ-SCHIP-1 is dependent on the presence of ␤IV-spectrin.
Discussion
Our results show that IQCJ-SCHIP-1 is a previously unidentified component of AISs and NRs. Thus, it is part of a small group of proteins specifically enriched in these two functionally critical regions of the axon, which includes cell adhesion molecules Nr-CAM and NF186 (Davis et al., 1996) , voltage-gated sodium channels (Caldwell et al., 2000; Boiko et al., 2001; Jenkins and Bennett, 2001) , and cytoskeleton-associated proteins AnkG (Kordeli et al., 1995) and ␤IV-spectrin (Berghs et al., 2000) . These proteins are all components of AISs and NRs in both the central and peripheral nervous systems and are thus likely to be the core of functionally important multimolecular complexes. Indeed, several studies indicate that they are physically associated (Ratcliffe et al., 2001; Lemaillet et al., 2003; Pan et al., 2006; Yang et al., 2007) . Moreover, their accumulation is dependent on each other. AnkG is a central player in all cases, but the mechanisms are different in AISs and NRs. At AISs, AnkG appears to play the initial role, and its targeting depends on intracellular determinants (Zhou et al., 1998; Dzhashiashvili et al., 2007) . In contrast, the interaction of NF186 with glial partners is the initial step in NR formation, allowing the recruitment of AnkG (Sherman et al., 2005; Eshed et al., 2005; Dzhashiashvili et al., 2007) . Our results show that IQCJ-SCHIP-1 interacts directly with AnkG, which is necessary for the targeting of IQCJ-SCHIP-1 to AISs. However, it is not clear whether Ank G is sufficient for the accumulation of IQCJ-SCHIP-1 at NRs, because we found that this protein did not accumulate at CNS NRs of qv 3J mice, which lack detectable ␤IV-spectrin but not the other components (Yang et al., 2004) . This result suggests that the accumulation of IQCJ-SCHIP-1 is also dependent on the presence of ␤IV-spectrin. Further work will be required to determine whether IQCJ-SCHIP-1 interacts directly with ␤IV-spectrin and the role of this hypothetical interaction in its targeting to NRs and AISs.
Developmental studies indicated that IQCJ-SCHIP-1 clustering at NRs and AISs occurs after Na v , which is among the last proteins to accumulate in these regions. The other proteins of the complex accumulate earlier at AISs and NRs Bennett, 2001, 2002) . The late accumulation of IQCJ-SCHIP-1 at NRs and AISs suggests that it plays a role in mature NRs and AISs rather than during their formation. Therefore it may be speculated that IQCJ-SCHIP-1 participates in long-term stabilization and/or regulates functions of multimolecular complexes associated with Na v channels in the axonal membrane at AISs and NRs.
The finding that IQCJ-SCHIP-1 interacts with calmodulin in the absence of Ca 2ϩ suggests that it could be involved in Ca 2ϩ signaling. IQCJ-SCHIP-1 could be the target of Ca 2ϩ effects if the release of bound calmodulin alters its functional properties or its interactions. Alternatively, IQCJ-SCHIP-1 could store calmodulin in AISs and NRs. Interestingly, although the role of Ca 2ϩ at NRs has not been extensively studied, Ca 2ϩ -ATPase, Ca 2ϩ /Na ϩ exchanger, and IP3R are enriched in these regions , suggesting that changes in cytosolic Ca 2ϩ play a functional role. Moreover, the function of several nodal proteins has been shown to be regulated by binding of Ca 2ϩ and/or calmodulin. For example, calmodulin modifies the inactivation kinetics of nodal Na v (Herzog et al., 2003) and inhibits the M-like current mediated by KCNQ2 (Gamper and Shapiro, 2003) . Therefore, IQCJ-SCHIP-1 could provide a pool of calmodulin, available for the regulation of nodal channels.
IQCJ-SCHIP-1 could also participate in the stabilization of multimolecular complexes associated with Na v channels in the axonal membrane at AISs and NRs. In line with this idea, ␤IV-spectrin is now thought to participate in the long-term stabilization of AISs and NRs rather than in their formation. Elimination of ␤IV-spectrin expression by RNA interference does not prevent the other components from initially accumulating at AISs Dzhashiashvili et al., 2007) , whereas NRs are formed in the PNS of ␤IV-spectrin-null mice, albeit in decreased numbers (Komada et al., 2002) . Moreover, the decreased staining of AnkG and Na v observed in AISs and NRs of qv 3J mice accentuates with age (Yang et al., 2004 (Yang et al., , 2007 . Interestingly, evidence that AnkG and ␤IV-spectrin are not the only organizers of AISs and NRs was provided by Xu and Shrager (2005) , who reported that disruption of Na v expression in vitro prevented the accumulation of AnkG, NF186, and NrCAM at AISs. These results indicate that a variety of protein-protein interactions may be necessary for the formation and/or stabilization of AISs and NRs. IQCJ-SCHIP-1 could also participate in the stabilization of AISs and NRs.
Finally, it is interesting to point out that IQCJ-SCHIP-1 could play a role in pathology. SCHIP1 gene is located in a genomic region that has been linked to autism (Auranen et al., 2003) . Furthermore, a 3q25-29 inversion in the vicinity of SCHIP-1 gene associated with a significant diminution of IQCJ-SCHIP-1 expression was reported in a patient with language impairment. Other proteins located in myelinated fibers have also been linked to autism. Calmodulin-binding sequence of the nodal Na v 1.2 was mutated in an autistic family (Weiss et al., 2003) . More recently, three independent studies identified a series of functional variants in the CNTNAP2 gene, which codes for the paranodal protein Caspr2, implicating this gene as a cause of autism in the general population (Alarcó n et al., 2008; Arking et al., 2008; Bakkaloglu et al., 2008) . The localization of IQCJ-SCHIP-1 in the NR provides additional evidence that alteration of the nodal region of myelinated fibers may be involved in language and autism-spectrum disorders.
Our results show that IQCJ-SCHIP-1 is a novel component of AISs and NRs and that its enrichment in these regions is dependent on AnkG and ␤IV-spectrin. The ability of IQCJ-SCHIP-1 to interact with calmodulin in the absence of Ca 2ϩ suggests that it may participate in Ca 2ϩ signaling in these regions. Developmental studies indicated that IQCJ-SCHIP-1 clustering at NRs and AISs occurs after their formation, suggesting that IQCJ-SCHIP-1 plays a role in mature NRs and AISs, possibly in the long-term stabilization or function of multimolecular complexes associated with Na v channels in the axonal membrane.
